The income statement of Protagonist Therapeutics Inc (PTGX) provides a snapshot of the company's financial performance over a specific period. It includes information about the revenue generated, expenses incurred, and the resulting net income. By analyzing the income statement, investors can assess the company's profitability and growth potential.
EBIT, or earnings before interest and taxes, is a measure of a company's operating profitability. It is calculated by subtracting the expenses related to interest and taxes from the operating income. EBITDA, on the other hand, stands for earnings before interest, taxes, depreciation, and amortization. It offers a clearer picture of a company's cash flow by removing the effects of non-operating items such as depreciation and amortization.
Gross profit is an important metric for Protagonist Therapeutics Inc as it represents the revenue generated from sales minus the cost of goods sold (COGS). It reflects the company's ability to produce goods or deliver services efficiently and effectively.
Net income from stockholders refers to the profit earned by Protagonist Therapeutics Inc that is available to its stockholders after deducting all expenses, including interest and taxes. It is an important metric as it indicates the company's financial performance and the extent to which stockholders can be rewarded.
Total revenue is the sum of all revenue generated by Protagonist Therapeutics Inc through its sales of goods or services. It is a key indicator of the company's overall financial health and growth prospects. It is calculated by multiplying the quantity of goods or services sold with their respective prices.
The balance sheet of Protagonist Therapeutics Inc provides a snapshot of the company's financial position at a specific point in time. It consists of three main sections: assets, liabilities, and equity. It is a crucial document for investors and stakeholders as it outlines the company's financial health, solvency, and the value of its resources.
Cash equivalents refer to highly liquid assets held by Protagonist Therapeutics Inc that can be converted into cash within a short period, typically within three months. Examples of cash equivalents include Treasury bills, short-term government bonds, and money market funds. They play an important role in the company's liquidity management.
Net debt is a measure of Protagonist Therapeutics Inc's overall indebtedness. It is calculated by subtracting the company's cash and cash equivalents from its total debt. A negative net debt indicates that the company has more cash than debt, which is generally considered positive as it signifies a strong financial position.
Stockholders' equity, also known as shareholders' equity, represents the residual value of Protagonist Therapeutics Inc's assets after deducting its liabilities. It reflects the shareholders' ownership interest in the company and is an important measure of its financial health and stability. Stockholders' equity is calculated by subtracting the company's total liabilities from its total assets.
Total assets represent all the resources owned by Protagonist Therapeutics Inc, including cash, investments, inventory, property, and equipment. They provide an overview of the company's financial health and its ability to generate future revenue and profits. The total assets figure is important for investors and creditors as it indicates the company's value and its ability to meet its financial obligations.
Total debt represents the sum of all Protagonist Therapeutics Inc's outstanding debt obligations. It includes both short-term and long-term debt, such as bank loans, bonds, and lines of credit. Total debt is an important metric for investors and creditors as it reflects the company's borrowing capacity and its ability to meet its financial obligations on time.
Total liabilities represent Protagonist Therapeutics Inc's obligations or debts to external parties, including creditors, suppliers, and lenders. The liabilities section of the balance sheet includes both current and long-term liabilities. Investors and creditors analyze this figure to assess the company's financial stability and its ability to meet its obligations.
Cash flow refers to the movement of money in and out of Protagonist Therapeutics Inc over a specific period. It is divided into three categories: operating, investing, and financing activities. Operating cash flow reflects the company's cash generated from core business operations, while investing cash flow represents the cash spent on acquiring or disposing of assets. Financing cash flow includes cash flows related to equity or debt financing activities, such as issuing or repurchasing stocks or bonds.
Free cash flow is an important financial metric for Protagonist Therapeutics Inc as it represents the cash generated by the company after deducting capital expenditures. It indicates the amount of cash available for reinvestment in the business, debt repayment, or distribution to shareholders. Positive free cash flow is generally a positive sign for investors, as it suggests the company has excess cash for growth or other strategic initiatives.
Investing cash flow represents the cash flows related to the acquisition or sale of long-term assets by Protagonist Therapeutics Inc. It includes cash spent on purchasing property, plant, and equipment, as well as cash received from the sale of these assets. This metric is important for investors and stakeholders as it reflects the company's investment activities and its commitment to long-term growth.
Operating cash flow refers to the cash generated by Protagonist Therapeutics Inc from its core business operations. It reflects the company's ability to generate profits from its main activities and is an important measure of its financial health. Operating cash flow can be used for various purposes, including reinvestment in the business, debt repayment, or distribution to shareholders.